GSK plc today announced the opening of a new, S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore. The opening of the facility was …
GSK opens first-in-Singapore high potency manufacturing and …
Nov 17, 2022 · GSK opens S$44mil high potency facility in its strategic New Product Introduction site in Singapore to meet increasing global demand for oncology treatments.
GSK debuts new $33M high-potency Singapore plant focused on …
Nov 17, 2022 · GSK continues to grow its manufacturing footprint in Singapore with the opening of a new 44 million Singapore dollar ($33 million) (PDF) plant that will be focused on producing …
GSK opens first high-potency facility in Singapore to produce …
Nov 17, 2022 · SINGAPORE - GSK officially opened its first high-potency manufacturing and test facility in Singapore on Thursday, with the capability to manufacture highly potent components …
FDA approves GSK’s BLENREP (belantamab mafodotin-blmf) for …
Aug 6, 2020 · GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved BLENREP (belantamab mafodotin-blmf) as a …
GSK’s investigational BCMA antibody-drug conjugate receives ...
Nov 2, 2017 · GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for …
SGD-1269 (SG9) | Drug Information, Uses, Side Effects, Chemistry ...
Selectively targets cancer cells expressing mutant epidermal growth factor receptor (EGFR) vIII or over expressing wild type EGFR. Depatuxizumab mafodotin acts on these cells to inhibit …
Pharma giant GSK opens $130m manufacturing facility in Singapore
On 5 July 2019, global healthcare company GSK opened a new $130 million pharmaceutical manufacturing facility in Jurong that was developed as part of the GSK-Economic …
GSK’s Tuas vaccine facility is Singapore’s largest after over $300m ...
Nov 18, 2024 · SINGAPORE - The expansion of British drugmaker GSK’s facility in Tuas has earned the title of Singapore’s largest vaccine production site based on a cumulative …
Pharmaceutical firm GSK opens $130m manufacturing facility in …
Jul 5, 2019 · Multinational pharmaceutical company GlaxoSmithKlyne (GSK) launched two new manufacturing continuous facility and an expanded production building at its Jurong site. …